The skin, being a multifaceted organ, performs a pivotal function in the complicated wound-healing procedure, which encompasses the triggering of several cellular entities and signaling cascades.
The Daviess Community Hospital Wound Care Center announces the introduction of MIST ... MIST Therapy uses low-frequency ultrasound delivered through a saline mist to stimulate the body’s natural ...
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
There is a global shortage of saline intravenous (IV) fluids used to treat common medical conditions in humans and animals. A Newcastle vet noticed Lifeblood discarding small amounts of saline ...
Hot chocolate and churros on a cold day. Cinnamon buns from Knaus Berry Farm. And a car wash at El Car Wash. More than 40 El Car Wash locations sprawl across South Florida, and it’s common to ...
This post expresses the views and opinions of the author(s) and not necessarily that of The Saline Post management or staff. When I read the recent post, Why Do We Need a Dam Anyway?, I realized that ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...